![Gerald Quirk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gerald Quirk
Direttore Finanziario/CFO presso
SYROS PHARMACEUTICALS, INC.
Profilo
Gerald E.
Quirk currently works at Syros Pharmaceuticals, Inc., as Director, Chief Financial & Accounting Officer from 2025.
Mr. Quirk also formerly worked at Choate, Hall & Stewart LLP, as Chairman-Life Sciences Group from 2012 to 2015, Genzyme Corp., as Managing Corporate Counsel from 1998 to 2006, Palmer & Dodge LLP, as Associate-Business Law Department, Infinity Pharmaceuticals, Inc., as Secretary, VP-Corporate Affairs & General Counsel from 2009 to 2012, Tokai Pharmaceuticals, Inc., as Executive VP-Business Operations & General Counsel from 2015 to 2016, and Syros Pharmaceuticals, Inc., as Chief Legal & Administrative Officer from 2017 to 2022.
Mr. Quirk received his graduate degree in 1991 from Harvard University, undergraduate degree in 1989 from Swarthmore College, and graduate degree in 1994 from Northeastern University.
Posizioni attive di Gerald Quirk
| Società | Posizione | Inizio |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 22/11/2024 |
Precedenti posizioni note di Gerald Quirk
| Società | Posizione | Fine |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Direttore Amministrativo | 01/03/2022 |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel proprietary therapies for the treatment of prostate cancer and other hormonally driven diseases | Consigliere Generale | 31/08/2016 |
Choate, Hall & Stewart LLP
 Choate, Hall & Stewart LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/05/2015 |
| INFINITY PHARMACEUTICALS, INC. | Contatto Relazioni con gli Investitori | 01/08/2012 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/09/2006 |
Formazione di Gerald Quirk
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
73
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Choate, Hall & Stewart LLP
Choate, Hall & Stewart LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Palmer & Dodge LLP
 Palmer & Dodge LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Swarthmore College
 Swarthmore College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel proprietary therapies for the treatment of prostate cancer and other hormonally driven diseases | Health Technology |
Syros Pharmaceuticals, Inc.
 Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
